Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tsukasa Kimata"'
Autor:
Yuko, Takahara, Junji, Tanahashi, Kaoru, Murota, Mihoko, Imai, Yusuke, Takagi, Tsukasa, Kimata
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(6)
Neuropathic pain in patients with cancer often do not respond to both opioid and non-opioid analgesics. Tapentadol has two medical effects: action on the μ opioid receptor and inhibition of noradrenaline reuptake; thus, it is expected to be effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b526e7cc468eafe9393cafcba0ad902
https://pubmed.ncbi.nlm.nih.gov/34139729
https://pubmed.ncbi.nlm.nih.gov/34139729
Autor:
Junko Kuroda, Shigeru Kusumoto, Tsukasa Kimata, Tomomi Kataoka, Satoshi Hibi, Shigeki Nakane, Masakazu Choshi, Yuusuke Tashiro, Masashi Takemoto, Yasuhito Tanaka, Hirokazu Komatsu, Kenji Kawada, Kei Muro, Kazunori Kimura
Background: There is little evidence regarding the risk of hepatitis B virus (HBV) reactivation in solid tumor patients without hepatitis B surface antigen (HBsAg), but with antibodies against hepatitis B core antigen (anti-HBc) and/or antibodies aga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3541aace8023b0986cf06f89a90ae869
https://doi.org/10.21203/rs.3.rs-92817/v1
https://doi.org/10.21203/rs.3.rs-92817/v1
Autor:
Yuko, Takahara, Hiroki, Yoshida, Masato, Suzuki, Akihide, Makihara, Ryota, Mitsuya, Tsukasa, Kimata
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(7)
Denosumab is widely used for treating bone metastases in patients with advanced cancer. However, hypocalcemia has been reported as a serious adverse effect during this treatment. Therefore, monitoring serum calcium concentration is essential. During
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de11cd1d06079f33509bf1d6a7fc99c6
https://pubmed.ncbi.nlm.nih.gov/32668852
https://pubmed.ncbi.nlm.nih.gov/32668852
Publikováno v:
Japanese Journal of Environmental Infections. 28:166-172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b3c90c50aa7817e235c0e0ba756b0bc
https://doi.org/10.4058/jsei.28.166
https://doi.org/10.4058/jsei.28.166
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(9)
During administration of thecisplatin (CDDP)containing regimen, hospitalization is necessary to ensure adequate hydration. However, short hydration is widely used when administering CDDP in outpatient chemotherapy centers.To assess the safety of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae4ee9dc2bf35b6e37c3a37d93c5626a
https://pubmed.ncbi.nlm.nih.gov/27628548
https://pubmed.ncbi.nlm.nih.gov/27628548
Autor:
Tsukasa, Kimata, Eiji, Sakamoto, Aya, Kawachi, Yayoi, Takahashi, Asako, Kuroki, Masashi, Nakamura, Yoshihiro, Kawade, Kenji, Tokui, Tatsuya, Suzuki, Takashi, Oyama, Toshiki, Uchida, Tomonori, Yamada, Masahiro, Kondoh, Michinori, Ogura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 37(8)
Therapy with mFOLFOX6/FOLFIRI used in treating colorectal cancer is typical of the regimens performed in outpatient settings. In this therapy, 46-h continuous infusion of 5-fluorouracil (5-FU) with concomitant oxaliplatin and irinotecan hydrochloride
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::388bcd890904c05aa3607e9b28f29a73
https://pubmed.ncbi.nlm.nih.gov/20716877
https://pubmed.ncbi.nlm.nih.gov/20716877
Autor:
Kenji Tokui, Yayoi Hayashi, Hiroaki Yuasa, Tsukasa Kimata, Kazuharu Uchida, Toshitaka Nabeshima, Takeharu Itatsu
Publikováno v:
Therapeutic drug monitoring. 26(3)
The present study aims to determine the population pharmacokinetic parameters of cyclosporine (CsA) after multiple oral administration of the microemulsion formulation, Neoral, in kidney transplant patients and to propose a limited sampling strategy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d95b3e2aa5e5823affff9b7635ddd5
https://pubmed.ncbi.nlm.nih.gov/15167630
https://pubmed.ncbi.nlm.nih.gov/15167630
Autor:
Katsumi Hayashi, Etsuro Orito, Tsukasa Kimata, Aya Kawachi, Masato Suzuki, Kazuki Inaba, Hiroshi Kanie, Toshihiro Owaki, Akira Sawaki
Publikováno v:
Journal of Clinical Oncology. 31:10543-10543
10543 Background: Imatinib concentrations at one month after the start of imatinib have shown an association with clinical benefit in pts with gastrointestinal stromal tumors (GISTs) and a significant decrease of 30% within twelve months. This retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32f79f7ca44415931eabccdbcb14a06f
https://doi.org/10.1200/jco.2013.31.15_suppl.10543
https://doi.org/10.1200/jco.2013.31.15_suppl.10543